Overall, these data suggest that ACF blocks STAT5A/5B expression in both CML and AML cells and that inhibition of cell growth induced by ACF may depend on STAT5 down‐regulation rather than STAT3 activation. The gene discussed is STAT5B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.